Provention Bio

money and shares declining
Biotech

Provention snags $60M to prep for diabetes drug launch

Provention Bio may be waiting a bit longer for the FDA's decision on its diabetes drug, but at least they have $60 million cash in the meantime.
Gabrielle Masson Jul 8, 2022 10:52am
Delayed on hold

FDA delays review of Provention Bio's embattled diabetes drug

Jun 30, 2022 7:21pm
diabetes testing supplies

Provention med for delaying diabetes clear for FDA resubmission

Jan 27, 2022 4:54pm
generic revolving door

Provention hires 3rd exec as it awaits FDA meeting for lead drug

Nov 17, 2021 10:31am
FDA Building 2

Provention Bio hires early research exec from Gossamer

Nov 8, 2021 7:05am
diabetes strip blood glucose monitor

Provention will wait for FDA to 'opine' on new teplizumab data

Sep 13, 2021 10:25am